Join to View Full Profile
1275 York AvenueNew York, NY 10065
Dr. Bakouny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Ziad Bakouny, MD, MSc is a Hematology/Oncology fellow at Memorial Sloan Kettering Cancer Center. Ziad has published over 100 PubMed-indexed peer-reviewed articles in journals including The Lancet, Nature Medicine, Nature Communications, Nature Reviews Clinical Oncology, Cancer Cell, Cancer Discovery, Science Translational Medicine, Journal of Clinical Oncology, JAMA Oncology, Annals of Oncology, Clinical Cancer Research & European Urology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2023
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2021 - 2023
St Joseph's University Medical SchoolClass of 2018
Certifications & Licensure
NY State Medical License 2023 - 2027
MA State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysis.Chris Labaki, Marc Eid, Ziad Bakouny, Charbel Hobeika, Razane El Hajj Chehade
European Journal of Cancer. 2025-04-30 - 3 citationsGuide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice.Nazli Dizman, Ziad Bakouny, Tarek Haykal, Ivy Riano, Aakash Desai
JCO Oncology Practice. 2025-03-01 - A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancer.Daniel Boiarsky, Alok K Tewari, Doga C Gulhan, Ziad Bakouny, Guruprasad Ananda
The Prostate. 2024-12-01
Authored Content
- Investigators Seek Expanded Use of Checkpoint Inhibitors in RCC12/5/2018
Press Mentions
Patients with Cancer and a Suppressed Immune System Are at High Risk for Severe COVID if Treated with Systemic Drug Therapies, Study FindsNovember 3rd, 2022- Disruption to Oncology Clinical Trials Seen Early in PandemicJune 15th, 2022
- Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data from Two Large US Cancer CentersJune 15th, 2022
- Join now to see all
Other Languages
- Arabic, French, Spanish
External Links
- Researchgate profilehttps://www.researchgate.net/profile/Ziad_Bakouny
- Google Scholar profilehttps://scholar.google.com/citations?user=cSTV2eUAAAAJ&hl=en
- Pubmed publicationshttps://www.ncbi.nlm.nih.gov/pubmed/?term=Bakouny+Z
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
